脑白质变性与阿尔茨海默病相关性的研究进展

doi:10.3969/j.issn.1003-9198.2021.06.024

摘要/Abstract

中图分类号:

R 749.1

侯永兰, 朱爱琴. 脑白质变性与阿尔茨海默病相关性的研究进展[J]. 实用老年医学, 2021, 35(6): 627-630.

[1] PLASSMAN B L,LANGA K M,FISHER G G, et al. Prevalence of dementia in the United States: the aging, demographics, and memory study[J]. Neuroepidemiology, 2007, 29(1/2): 125-132.
[2] DAVIS M, O CONNELL T, JOHNSON S, et al. Estimating Alzheimer’s disease progression rates from normal cognition through mild cognitive impairment and stages of dementia[J]. Curr Alzheimer Res, 2018, 15(8): 777-788.
[3] COSTANZA A, XEKARDAKI A, KÖVARI E, et al. Microvascular burden and Alzheimer-type lesions across the age spectrum[J]. J Alzheimers Dis, 2012, 32(3):643-652.
[4] DEVINE M E, FONSECA J A, WALKER Z.Do cerebral white matter lesions influence the rate of progression from mild cognitive impairment to dementia?[J]. Int Psychogeriatr, 2013, 25(1): 120-127.
[5] LAUNER L J,BERGER K,BRETELER M M B, et al. Regional variability in the prevalence of cerebral white matter lesions: an MRI study in 9 European countries (CASCADE)[J]. Neuroepidemiology, 2006, 26(1): 23-29.
[6] VAN DIJK E J, PRINS N D, VROOMAN H A, et al. Progression of cerebral small vessel disease in relation to risk factors and cognitive consequences: Rotterdam Scan Study[J]. Stroke, 2008, 39(10):2712-2719.
[7] GUNNING-DIXON F M,RAZ N.The cognitive correlates of white matter abnormalities in normalaging: a quantitative review[J]. Neuropsychology, 2000, 14(2): 224-232.
[8] SPRINT MIND Investigators for the SPRINT Research Group. Association of intensive vs standard blood pressure control with cerebral white matter lesions[J]. JAMA, 2019, 322(6): 524-534.
[9] LUCATELLI P, MONTISCI R, SANFILIPPO R, et al. Is there an association between leukoaraiosis volume and diabetes?[J]. J Neuroradiol, 2016, 43(4): 273-279.
[10]CAO L, GUO Y, ZHU Z. Effects of hyperhomocysteinemia on ischemic cerebral small vessel disease and analysis of inflammatory mechanisms[J]. Int J Neurosci, 2021,131(4):362-369.
[11]VERHAAREN BENJAMIN F J, STÉPHANIE D,BIS JOSHUA C, et al. Multiethnic genome-wide association study of cerebral white matter hyperintensities on MRI[J]. Circ Cardiovasc Genet, 2015, 8(2): 398-409.
[12]TURNER S T, JACK C R, FORNAGE M, et al. Heritability of leukoaraiosis in hypertensive sibships[J]. Hypertension, 2004, 43(2):483-487.
[13]ROSENBERG G A, BJERKE M, WALLIN A. Multimodal markers of inflammation in the subcortical ischemic vascular disease type of vascular cognitive impairment[J]. Stroke, 2014, 45(5):1531-1538.
[14]SIMPSON J E, WHARTON S B, COOPER J, et al. Alterations of the blood-brain barrier in cerebral white matter lesions in the ageing brain[J]. Neurosci Lett, 2010, 486(3): 246-251.
[15]HUANG W Q,YI K H, ZHI L, et al. DNA Methylation profiling reveals the change of inflammation-associated ZC3H12D in leukoaraiosis [J]. Front Aging Neurosci, 2018,10:143.
[16]SIMPSON J E, HOSNY O, WHARTON S B, et al. Microarray RNA expression analysis of cerebral white matter lesions reveals changes in multiple functional pathways[J]. Stroke, 2009,40(2):369-375.
[17]RAJA R, ROSENBERG G, CAPRIHAN A. Review of diffusion MRI studies in chronic white matter diseases[J]. Neurosci Lett, 2019,694:198-207.
[18]CHARLTONR A, SCHIAVONE F, BARRICK T R, et al. Diffusion tensor imaging detects age related white matter change over a 2 year follow-up which is associated with working memory decline[J]. J Neurol Neurosurg Psychiatry, 2010,81(1):13-19.
[19]O’SULLIVAN M, SUMMERS P E, JONES D K, et al. Normal-appearing white matter in ischemic leukoaraiosis: a diffusion tensor MRI study[J]. Neurology,2001,57(12):2307-2310.
[20]MCALEESE K E, FIRBANK M, DEY M, et al. Cortical tau load is associated with white matter hyperintensities[J]. Acta Neuropathol Commun, 2015,3:60.
[21]王建华,冯荣芳,李志立,等.阿尔茨海默病脑白质病变与认知功能的相关性[J]. 中国老年学杂志,2013,33(21):5253-5255.
[22]VIBHA D, TIEMEIER H, MIRZA S S, et al. Brain volumes and longitudinal cognitive change: a population-based study[J]. Alzheimer Dis Assoc Disord, 2018,32(1):43-49.
[23]NORDAHL C W, RANGANATH C, YONELINAS A P, et al. White matter changes compromise prefrontal cortex function in healthy elderly individuals[J]. J Cogn Neurosci, 2006,18(3):418-429.
[24]SILBERT L C, NELSON C, HOWIESON D B, et al. Impact of white matter hyperintensity volume progression on rate of cognitive and motor decline[J]. Neurology, 2008,71(2):108-113.
[25]DE GROOT J C, DE LEEUW F E, OUDKERK M, et al. Cerebral white matter lesions and cognitive function: the Rotterdam Scan Study[J]. Ann Neurol, 2000,47(2):145-151.
[26]MORTAMAIS M, REYNES C, BRICKMAN A M, et al. Spatial distribution of cerebral white matter lesions predicts progression to mild cognitive impairment and dementia[J]. PLoS One, 2013,8(2):e56972.
[27]TULLBERG M, FLETCHER E, DECARLI C, et al. White matter lesions impair frontal lobe function regardless of their location[J]. Neurology, 2004,63(2):246-253.
[28]KIM J H, HWANG K J, KIM J H, et al. Regional white matter hyperintensities in normal aging, single domain amnestic mild cognitive impairment, and mild Alzheimer’s disease[J]. J Clin Neurosci, 2011,18(8):1101-1106.
[29]RÉMY F, VAYSSIÈRE N, SAINT-AUBERT L,et al. White matter disruption at the prodromal stage of Alzheimer’s disease: relationships with hippocampal atrophy and episodic memory performance[J]. Neuroimage Clin, 2015,7:482-492.
[30]CHRISTIANSEN K, AGGLETON J P, PARKER G D, et al. The status of the precommissural and postcommissural fornix in normal ageing and mild cognitive impairment: An MRI tractography study[J]. Neuroimage, 2016,130:35-47.
[31]CARDENAS V A, TOSUN D, CHAO L L, et al. Voxel-wise co-analysis of macro-and microstructural brain alteration in mild cognitive impairment and Alzheimer’s disease using anatomical and diffusion MRI[J]. J Neuroimaging, 2014,24(5):435-443.
[32]ZHANG Y, SCHUFF N, JAHNG G H, et al. Diffusion tensor imaging of cingulum fibers in mild cognitive impairment and Alzheimer disease[J]. Neurology, 2007,68(1):13-19.
[33]MADHAVAN A, SCHWARZ C G, DUFFY J R, et al. Characterizing white matter tract degeneration in syndromic variants of Alzheimer’s disease: A Diffusion Tensor Imaging Study[J]. J Alzheimers Dis, 2016,49(3):633-643.
[34]杜灿,武洲,朱爱琴.高原慢性低氧环境慢性牙周炎与阿尔茨海默病的相关性[J]. 中华老年医学杂志,2015,34(4):452-454.
[35]HAMILTON N B, KOLODZIEJCZYK K, KOUGIOUMTZIDOU E, et al. Proton-gated Ca(2+)-permeable TRP channels damage myelin in conditions mimicking ischaemia[J]. Nature, 2016,529(7587):523-527.
[36]GAO L, TIAN S, GAO H,et al. Hypoxia increases Aβ-induced tau phosphorylation by calpain and promotes behavioral consequences in AD transgenic mice[J]. J Mol Neurosci, 2013,51(1):138-147.
[37]OH-HASHI K, NAGAI T, TANAKA T,et al. Determination of hypoxic effect on neprilysin activity in human neuroblastoma SH-SY5Y cells using a novel HPLC method[J]. Biochem Biophys Res Commun, 2005,334(2):380-385.
[38]DAULATZAI M A. Quintessential risk factors: their role in promoting cognitive dysfunction and Alzheimer’s disease[J]. Neurochem Res, 2012,37(12):2627-2658.

脑白质变性与阿尔茨海默病相关性的研究进展

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

Metrics

推荐阅读 10

[1]	孙丽, 尹卫红, 经俊, 钱夏丽. 亚麻醉剂量艾司氯胺酮对老年脊柱手术病人术后早期认知功能障碍的影响[J]. 实用老年医学, 2024, 38(10): 1039-1043.
[2]	陈昕露, 周艺铭, 韩雪, 顾小萍. 睡眠障碍与老年术后认知功能障碍的双向关联研究进展[J]. 实用老年医学, 2024, 38(5): 433-437.
[3]	蔡文岚, 孙杰. 老年病人术后认知功能障碍的风险因素研究进展[J]. 实用老年医学, 2024, 38(5): 438-437.
[4]	赵倩文, 孙斌, 朱杨子, 顾小萍, 王立伟. 老年病人术后认知功能障碍诊断与干预策略的研究进展[J]. 实用老年医学, 2024, 38(5): 447-437.
[5]	郭金花, 申铁梅, 陈凌, 崔虹, 王小霞, 黄巧, 黄芳, 李芸, 杨满青. 广东省农村老年人认知功能现状及影响因素分析[J]. 实用老年医学, 2024, 38(5): 456-437.
[6]	隗倩, 蔡颖源, 王珊, 谈福云, 陆小伟. 甲状腺功能正常及亚临床甲状腺功能减退的老年人血清促甲状腺激素水平与认知障碍的相关性[J]. 实用老年医学, 2024, 38(5): 486-437.
[7]	张卉, 李霞. 痴呆前心理行为障碍预测阿尔茨海默病的研究进展[J]. 实用老年医学, 2024, 38(5): 512-437.
[8]	焦琳娜, 李宝仪, 王琴, 何建丽. 脑白质病变及大脑皮层厚度与老年轻型卒中后认知功能障碍的相关性研究[J]. 实用老年医学, 2024, 38(3): 287-290.
[9]	董丽华, 李加梅, 郑加平, 雷小晶. 血液生物标志物在阿尔茨海默病早期诊断中的研究进展[J]. 实用老年医学, 2023, 37(12): 1249-1254.
[10]	张伟, 王蓉. 衰老作为神经退行性疾病危险因素的科学现状分析[J]. 实用老年医学, 2023, 37(10): 984-988.
[11]	时建铨, 郑慧芬, 徐畅, 王变荣. 认知障碍简明评价量表与Addenbrooke认知评估量表Ⅲ诊断阿尔茨海默病的准确性比较[J]. 实用老年医学, 2023, 37(10): 1041-1043.
[12]	阎子花, 杜静, 宋竹梅, 张兴梅, 张楠. 痴呆病人病感失认测评工具的研究进展[J]. 实用老年医学, 2023, 37(10): 1059-1063.
[13]	王琳琳, 杨诗怡, 徐俊. 人工智能在阿尔茨海默病中的研究进展[J]. 实用老年医学, 2023, 37(9): 869-872.
[14]	王敏, 郭文军, 汤忠泉, 赵晓敏, 欧婷, 李云涛. 听力障碍与阿尔茨海默病相关性的Meta分析[J]. 实用老年医学, 2023, 37(9): 915-919.
[15]	吕坤, 曹纹平, 王宇航, 赵春生, 曹胜武. 不同麻醉方式在帕金森病病人丘脑底核脑深部电刺激手术中的临床效果[J]. 实用老年医学, 2023, 37(9): 938-942.